Bp Consulting, Inc   Report issue

For profit Phase 4
Founded: Tokyo Japan (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2007
NCT00822081
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cataract (Phase 4)

Dry Eye Syndromes (Phase 4)

Edema (Phase 4)

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 4)

Hypertension (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Macular Edema (Phase 4)

Myopia (Phase 4)

Ocular Hypertension (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 18